BIO US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing. Innovation Boom or Bust? Industry Gauges Impact of SCOTUS Ruling on Gene Patents Premium Industry reactions to the US Supreme Court's decision to invalidate patents on isolated gene sequences were immediate and ranged from elation to disappointment. Report: NIH's 2011 Funds Supported $62.1B in Economic Activity By Matt Jones USPTO Hearing on Confirmatory Gene Testing Raises Calls for Reform Outside Patent System Premium Originally published Feb. 17. By Turna Ray Supreme Court Case on Script Data Sale Presents 'Gray Area' for PBM Personalized Rx Efforts Premium A Supreme Court decision against drug developers in Sorrell v. IMS Health could potentially hamper how pharmacy benefit managers can use physician prescription data to drive adoption of pharmacogenomically guided products. Mar 30, 2011 Senate Close on SBIR Bill Feb 4, 2011 Patent Reform Back on Senate's Agenda Nov 3, 2010 US DoJ Argues Against Patenting Isolated Genes, But USPTO Will Maintain Status Quo Premium Jun 29, 2010 Narrow Ruling in Bilski Case Maintains Patentability of Diagnostics, other Biotech Inventions May 5, 2010 Report: More Life-Science Jobs Despite Recession; Fewer Patents in Top-10 States Feb 5, 2010 HHS Advisory Group Proposes Gene Patent Limits, Riles Industry Oct 29, 2009 BIO Report, Survey Reveal Importance of Academic Tech Licensing to US Economy Oct 2, 2009 Delays in Las Vegas Expansion Prompt BIO to Move 2012 Confab to Boston Premium Sep 4, 2009 Mass. Draft Greenhouse-Gas Regs Exclude Renewable Biomass; Foes Predict Pain for Biotechs Premium May 1, 2009 Life-Sci REITs HCP and BioMed Realty Report Q1 Financials; Update Leasing, Financing Activity Premium Apr 24, 2009 BioRegion Newsmakers, 2009.04.24 Premium Apr 22, 2009 FDA May Issue More White Papers on Rx/Dx Codevelopment, Woodcock Says At Meeting Premium Apr 8, 2009 Patent Reform Bill Moves to Senate; Biotech, University Groups Provide Measured Support Premium Apr 6, 2009 Ill. Life-Sci Group Expects State Lawmakers to Allocate $25M to Help Startups Launch Products Premium Apr 6, 2009 Around the Regions: April 6, 2009 Premium Mar 30, 2009 Maryland Lawmakers to Decide Final Figures for State's Contribution to Biotech Tax Credit Premium Mar 30, 2009 BIO to Study Plan to Expand NYC's Javits Center, Now Too Small for International Meeting Premium Mar 16, 2009 Georgia Senate OKs Bill Limiting Use of hESCs for IVF; House, Governor Must Still Approve Premium Mar 4, 2009 Tech Transfer Tidbits: Mar 4, 2009 Premium Mar 2, 2009 Around the Regions: March 2, 2009 Premium Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.